Effective 1 January 2025 the following amended pathology items will be listed on the MBS. Informational factsheets can be found below:

• Expansion of MBS item 73295 for BRCA variant testing to determine eligibility for a PBS treatment
• Expansion of MBS items 73303 and 73304 for BRCA variant testing in patients with prostate cancer to determine PBS eligibility

Further information can be found in the factsheets below:

Factsheet	PDF and Word versions
Expansion of BRCA variant testing in patients with ovarian, fallopian tube, primary peritoneal or breast cancer to determine eligibility for a relevant PBS treatment – Amended MBS item 73295 (Last updated: 21 February 2025)	Word Version - Expansion of MBS item 73295 (Word 128 KB) PDF Version - Expansion of MBS item 73295 (PDF 209 KB)
Expansion of BRCA variant testing in patients with metastatic castration-resistant prostate cancer to determine eligibility for a relevant PBS treatment – Amended MBS items 73303 and 73304 (Last updated: 20 December 2024)	Word Version - Expansion of MBS items 73303 and 73304 (Word 125 KB)Word PDF Version - Expansion of MBS items 73303 and 73304 (PDF 201 KB)